Integrin β4 attenuates SHP‐2 and MAPK signaling and reduces human lung endothelial inflammatory responses
- 21 April 2010
- journal article
- research article
- Published by Wiley in Journal of Cellular Biochemistry
- Vol. 110 (3), 718-724
- https://doi.org/10.1002/jcb.22582
Abstract
We previously identified the marked upregulation of integrin β4 in human lung endothelial cells (EC) treated with simvastatin, an HMG coA‐reductase inhibitor with vascular‐protective and anti‐inflammatory properties in murine models of acute lung injury (ALI). We now investigate the role of integrin β4 as a novel mediator of vascular inflammatory responses with a focus on mitogen‐activated protein kinases (MAPK) signaling and the downstream expression of the inflammatory cytokines (IL‐6 and IL‐8) essential for the full elaboration of inflammatory lung injury. Silencing of integrin β4 (siITGB4) in human lung EC resulted in significant increases in both basal and LPS‐induced phosphorylation of ERK 1/2, JNK, and p38 MAPK, consistent with robust integrin β4 regulation of MAPK activation. In addition, siITB4 increased both basal and LPS‐induced expression of IL‐6 and IL‐8 mRNA and protein secretion into the media. We next observed that integrin β4 silencing increased basal and LPS‐induced phosphorylation of SHP‐2, a protein tyrosine phosphatase known to modulate MAPK signaling. In contrast, inhibition of SHP‐2 enzymatic activity (sodium stibogluconate) abrogated the increased ERK phosphorylation associated with integrin β4 silencing in LPS‐treated EC and attenuated the increases in levels of IL‐6 and IL‐8 in integrin‐β4‐silenced EC. These findings highlight a novel negative regulatory role for integrin β4 in EC inflammatory responses involving SHP‐2‐mediated MAPK signaling. Upregulation of integrin β4 may represent an important element of the anti‐inflammatory and vascular‐protective properties of statins and provides a novel strategy to limit inflammatory vascular syndromes. J. Cell. Biochem. 110: 718–724, 2010.Keywords
This publication has 38 references indexed in Scilit:
- Endothelial cell barrier protection by simvastatin: GTPase regulation and NADPH oxidase inhibitionAmerican Journal of Physiology-Lung Cellular and Molecular Physiology, 2008
- Nonmuscle myosin light-chain kinase mediates neutrophil transmigration in sepsis-induced lung inflammation by activating β2 integrinsNature Immunology, 2008
- Interleukin-1β Causes Acute Lung Injury via αvβ5 and αvβ6 Integrin–Dependent MechanismsCirculation Research, 2008
- Mitogen-Activated Protein Kinases Regulate Susceptibility to Ventilator-Induced Lung InjuryPLOS ONE, 2008
- Statins for infection and sepsis: a systematic review of the clinical evidenceJournal of Antimicrobial Chemotherapy, 2008
- Intrinsic Signaling Functions of the β4 Integrin Intracellular DomainJournal of Biological Chemistry, 2007
- Integrin αvβ5 Regulates Lung Vascular Permeability and Pulmonary Endothelial Barrier FunctionAmerican Journal of Respiratory Cell and Molecular Biology, 2007
- β4 integrin activates a Shp2–Src signaling pathway that sustains HGF-induced anchorage-independent growthThe Journal of cell biology, 2006
- ERK1/2 mitogen-activated protein kinase selectively mediates IL-13-induced lung inflammation and remodeling in vivoJCI Insight, 2005
- Rhoa Function in Lamellae Formation and Migration Is Regulated by the α6β4 Integrin and Camp MetabolismThe Journal of cell biology, 2000